Thiotepa
規格
52-24-4CAS番号
200-135-7EC番号
tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphaneIUPAC名
C6H12N3PS化学式
189.22 g/mol分子量
thiotepa; 52-24-4; THIO-TEPA; Triethylenethiophosphoramide; Thiophosphamide; Thioplex; Tespamin; Tespamine; Thiofozil; Girostan; Tifosyl; Stepa; Oncotiotepa; TESPA; Thiotef; tepadina; Ledertepa; Tris(1-aziridinyl)phosphine sulfide; Thiotriethylenephosphoramide; NSC-6396; TIO TEF; Tepylute; Tiotepa; Thiophosphamidum; Triethylene thiophosphoramide; N,N',N''-Triethylenethiophosphoramide; Triaziridinylphosphine sulfide; Triethylenethiophosphorotriamide; Tris(ethylenimino)thiophosphate; Thiotepum; Phosphorothioic acid triethylenetriamide; Tri(ethyleneimino)thiophosphoramide; NSC 6396; DTXSID0021339; Tris(1-aziridinyl)phosphine sulphide; N,N',N''-Triethylenethiophosphamide; NSC6396; 1,1',1''-Phosphinothioylidynetrisaziridine; N,N',N''-Triethylenephosphorothioic triamide; N,N',N''-Tri-1,2-ethanediylthiophosphoramide; 905Z5W3GKH; AZIRIDINE,1,1',1''-PHOSPHINOTHIOYLIDYNETRIS-; WR 45312; DTXCID201339; tris(aziridin-1-yl)-lambda5-phosphanethione; tris(aziridin-1-yl)-sulfanylidenephosphorane; Thio Tepa; tris(aziridin-1-yl)-$l^(5)-phosphanethione; tris(aziridin-1-yl)-$l^{5}-phosphanethione; Thiofosfamide; AI3 24916; AI324916; RefChem:897941; L01AC01; N,N', N''-Triethylenethiophosphoramide; 1,1',1''-Phosphinothioyldynetrisaziridine; 1,1',1\"-phosphinothioylidynetrisaziridine; 200-135-7; TSPA; Tiofosfamid; Tri(aziridin-1-yl)phosphine sulfide; Oncotepa; Tiofosyl; Tiofozil; Oncothio-tepa; Tio-tef; Thio-Tep; Thio-tepa S; 1,1',1''-phosphorothioyltriaziridine; CBC 806495; Phosphine sulfide, tris(1-aziridinyl)-; NCI-C01649; SK 6882; Tris(aziridinyl)phosphine sulfide; Aziridine, 1,1',1''-phosphinothioylidynetris-; Tri-1-aziridinylphosphine sulfide; Tri(1-aziridinyl)phosphine sulfide; N,N',N''-Triethylenethiophosphortriamide; MFCD00145452; Thiophosphoramide, N,N',N''-tri-1,2-ethanediyl-; N,N',N''-Tri-1,2-ethanediylphosphorothioic triamide; MLS001333083; MLS003389372; Phosphorothioic triamide, N,N',N''-tri-1,2-ethanediyl-; AI 3-24916; Phosphorothioic triamide, N,N',N''-triethylene-; NCGC00095042-04; NCGC00095042-06; C6H12N3PS; Thiotepum [INN-Latin]; Tiotepa [INN-Spanish]; CAS-52-24-4; SMR000058542; CCRIS 586; HSDB 3258; AI3-24916; SR-05000001855; EINECS 200-135-7; BRN 0145978; UNII-905Z5W3GKH; WR-45312; thiotepa?; Thiotepa [USP:INN:BAN:JAN]; Tepadina (TN); Thioplex (TN); Rethio (TN); Thiotepa (Thioplex); Spectrum_001689; Thio-TEPA (Standard); THIOTEPA [HSDB]; THIOTEPA [IARC]; THIOTEPA [INN]; THIOTEPA [JAN]; Thiophosphoramide, N,N',N''-triethylene-; THIOTEPA [MI]; THIOTEPA [VANDF]; Spectrum2_001557; Spectrum3_001594; Spectrum4_000208; Spectrum5_001641; THIOTEPA [MART.]; tris(aziridin-1-yl)-thioxo-$l^{5}-phosphane; CHEMBL671; THIOTEPA [USP-RS]; THIOTEPA [WHO-DD]; Thioplex (TN) (Immunex); SCHEMBL4760; Thiotepa (JAN/USP/INN); THIOTEPA [EMA EPAR]; Thio-TEPA, 98%, solid; BSPBio_003188; KBioGR_000815; KBioSS_002169; 4-20-00-00052 (Beilstein Handbook Reference); MLS001333084; MLS002207150; MLS006009972; BIDD:GT0127; DivK1c_000817; SPECTRUM1503324; SPBio_001434; tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane; THIOTEPA [ORANGE BOOK]; CHEBI:9570; GTPL7622; orb1309233; THIOTEPA [USP MONOGRAPH]; HMS502I19; KBio1_000817; KBio2_002169; KBio2_004737; KBio2_007305; KBio3_002688; N,N''-Triethylenethiophosphamide; NINDS_000817; GLXC-06101; HMS1922A14; HMS2093E05; HMS2232P17; HMS3372D10; HMS3753E09; HMS5080I05; N,N''-Triethylenethiophosphoramide; Pharmakon1600-01503324; ALBB-034802; Tox21_111399; Tox21_400065; BDBM50418086; CCG-39776; EBC-06025; HY-17574R; MSK164080; NSC758455; s1775; AKOS005267118; CS-3119; DB04572; FT03758; NSC-758455; 1,1''-Phosphinothioylidynetrisaziridine; IDI1_000817; Thiophosphoramide,N',N'' -triethylene-; N,N',N'''-Triethylenethiophosphhoramide; NCGC00095042-01; NCGC00095042-02; NCGC00095042-03; NCGC00095042-05; NCGC00095042-07; NCGC00095042-08; NCGC00095042-09; NCGC00095042-14; PHOSPHOROTHIOIC TRI(ETHYLENEAMIDE); AS-16885; HY-17574; N,N''-Triethylenephosphorothioic triamide; NCI60_013117; 1,1',1''-Phosphorothioyltris(aziridine); SBI-0051814.P002; Aziridine,1',1''-phosphinothioylidynetris-; N,N''-Tri-1,2-ethanediylthiophosphoramide; Phosphorothioic triamide,N',N''-triethylene; Thiophosphoramide, N,N',N'' -triethylene-; NS00010011; WLN: T3NTJ APS&- AT3NTJ&- AT3NTJ; tris(aziridin-1-yl)-thioxo-lambda5-phosphane; 1-[Di(1-aziridinyl)phosphorothioyl]aziridine #; C07641; D00583; EN300-120883; Phosphorothioic triamide, N,N',N''-triethylene; Thiophosphoramide,N',N''-tri-1,2-ethanediyl-; AB00052346-06; AB00052346_07; N,N''-Tri-1,2-ethanediylphosphorothioic triamide; Q416507; SR-05000001855-1; SR-05000001855-5; 1,1',1''-PHOSPHINOTHIOYLIDYNETRIS(AZIRIDINE); BRD-K09631521-001-05-7; BRD-K09631521-001-09-9; BRD-K09631521-001-11-5; Phosphorothioic triamide,N',N''-tri-1,2-ethanediyl-; Z1201619320; Thiotepa, United States Pharmacopeia (USP) Reference Standard; 1631739-26-8別名
Thiotepaを含む製品
테파디나주400밀리그램(티오테파)테파디나주15밀리그램(티오테파), 테파디나주100밀리그램(티오테파)아테파주100밀리그램(티오테파)아테파주15밀리그램(티오테파)티오스팔피주15밀리그램(티오테파), 티오스팔피주100밀리그램(티오테파)TIOTEPA VIVANTA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTIOTEPA VIVANTA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTIOTEPA SEACROSS 100 MG POLVO PARA CONCETRADO PARA SOLUCION PARA PERFUSION EFGTIOTEPA KABI 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTIOTEPA KABI 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGTIOTEPA HIKMA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
1/4ページ
Thiotepaを販売する企業
ML
MSN LaboratoriesIndia(주
(주)동인제약Republic of KoreaNK
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.ChinaJH
Jiangsu Hengrui Pharmaceutical Co., Ltd.China1/3ページ